BUDAPEST, Jan 27 (Reuters) - Hungarian drugmaker Richter expects a contraceptive patch licensed from Bayer HealthCare to produce annual revenues worth 40-50 million euros in three to four years, Chief Executive Erik Bogsch told Reuters on Tuesday.
BUDAPEST, Jan 27 (Reuters) - Hungarian drugmaker Richter has entered a license and distribution agreement with Bayer HealthCare to sell a transdermal contraceptive patch in Europe and some Latin American countries, Richter said on Tuesday.
Companies Involved in Therapeutics Development AstraZeneca PLC Bayer AG Incuron, LLC Novartis AG Otsuka Holdings Co., Ltd. Salivary ..... AstraZeneca PLC, H2 2014 Salivary Gland Cancer - Pipeline by Bayer AG , H2 2014 Salivary Gland Cancer - Pipeline by Incuron
PARIS, Dec 17 (Reuters) - Sanofi said on Wednesday that Merial, its animal health unit, had reached an agreement with Bayer HealthCare to buy two Bayer equine health products for an undisclosed amount.
Nov 24 (Reuters) - Germany-based drugmaker Bayer AG is considering the sale of its diabetes device business, Bloomberg reported, citing sources.
by the drug division, Bayer reported strong third ..... expect the strong growth in pharmaceuticals sales (up 10% year over ..... growth as well. However, Bayer needs to accelerate its ..... consumer group. We believe Bayer can leverage is global
emerging-markets, reduced government budgets and increased R&D costs. For those wanting to buy, Novartis [ NVS ] and Bayer [ BAYN .ge/ BAYRY ] are attractive. Pg M7, Asia: Korean steel Posco [5490.sk/ PKX ] and Chinese car maker BYD [1211
order to acquire Cadence Pharmaceuticals . While the deal gives ..... example, we only downgraded Bayer 's BAYRY "> BAYRY issuer ..... will significantly expand Bayer 's already well-positioned ..... material science toward Bayer 's health-care operations
Canada’s Valeant Pharmaceuticals wants to acquire botox maker ..... May, Germany’s Bayer clinched a $14.2 ..... billion. In India, Sun Pharmaceuticals in April bought Ranbaxy Laboratories ..... consumer division to Bayer , according to Danzon. In addition
serve as chairman of the board. Andreas Fibig, a board member since 2011 and president and chairman of Bayer HealthCare Pharmaceuticals , will subsequently assume the reins. We think Fibig’s experience at several global health care firms